Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Broker tips: Ascential, CAB Payments

(Sharecast News) - Analysts at Berenberg upgraded business-to-business media firm Ascential to 'buy' from 'hold' and hiked their target price on the stock to 568.0p from 395.0p following a takeover offer from Informa. Berenberg stated Informa had made a firm offer for Ascential at 568.0p per share, in line with the possible offer price disclosed on 23 July, and representing a 53% premium to the closing price on 22 July and valuing the company on a CY24 and CY25 enterprise value/underlying earnings ratio of 15.7x and 13.8x, respectively, pre-synergies.

"The CY25 EV/EBITDA of 13.8x, pre synergies is higher than historical take-out multiples in the sector - Informa bought Tarsus for 12.5x EV/EBITDA in May 2023. It also bought UBM for 14.3x in January 2018. Hyve was also bought by Providence February 2023 at >11x EV/EBITDA. When we take into account the potential synergies and better-than-expected trading, we estimate the implied CY25 EV/EBITDA valuation to be c11.5," said Berenberg.

The German bank added that Informa noted in its H1 results that its larger events were growing at above-average rates, benefiting from scale economics, and that Ascential expects H124 revenue to be roughly £158.0m, as organic growth came to 15% year-on-year.

Over at Canaccord Genuity, analysts cut their target price on fintech group CAB Payments from 240.0p to 214.0p on Thursday following the group's H124 trading update.

Canaccord Genuity said CAB Payments' update highlighted the group's underlying outperformance relative to its estimated sector and subsector growth. However, CAB Payments also noted that conditions were difficult during the period.

"H124 results have suffered from the impact of lower revenues but also recurring operating costs being an estimated c.15% higher, due to the new business strain associated with an increased salesforce and establishment of EU and US offices," said Canaccord Genuity.

The Canadian bank said it was "disappointing" that short-term performance had fallen below its expectations but stated it was supportive of the strategy of continued investment in building out the platform, for what it believes to be a "valuable strategic asset".

With that said, Canaccord left its valuation methodology unchanged, stating that given a 17-19% cut to its adjusted underlying earnings and earnings per share forecasts, and a slight re-rating of the payments sector, this results in its new price target of 214.0p.

"If CAB can deliver against revised expectations, consistently, then the upside could be significant, hence we retain our 'speculative buy' rating," added the analysts.

Share this article

Related Sharecast Articles

London close: Stocks rise on US jobless claims, ECB rate cut
(Sharecast News) - London's stock markets closed with gains on Thursday, as investors digested an increase in US jobless claims and an interest rate cut from the European Central Bank.
Europe close: Stocks notch solid gains as ECB cuts rates
(Sharecast News) - European stocks rose for the second straight day on Thursday after the European Central Bank kept to the script to cut interest rates for the second time this year.
Broker tips: James Fisher and Sons, Trainline
(Sharecast News) - Canaccord Genuity has cut its rating for James Fisher and Sons from 'buy' to 'hold', saying that the marine engineering services group still has a long way to go in its turnaround.
Director dealings: Genus director makes share purchase
(Sharecast News) - Genus revealed on Thursday that senior independent director Lesley Knox had acquired 2,800 ordinary shares in the FTSE 250-listed genetics firm.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.